In many clinical trials studying neurodegenerative diseases such as Parkinsons disease(PD),multiple longitudinal outcomes are collected to fully explore the multidimensional impairment caused by this disease.If the outcomes deteriorate rapidly,patients may reach a pre-defined level of functional disability,which is considered to be a terminal event because these patients would then initiate symptomatic treatment of levodopa to ameliorate the clinical outcomes.